The UCLA Institute for Precision Health (IPH) serves as a nexus for interdisciplinary collaboration across the David Geffen School of Medicine (DGSOM), UCLA Health System and the University. In 2016, in collaboration with the Clinical and Translational Science Institute (CTSI), the Institute for Precision Health (IPH) launched the ATLAS Community Health Initiative to engage a diverse sample of patients across UCLA Health in precision health research. ATLAS, or At Los Angeles, aims to enroll at least 150,000 patients across the health system with the goal of creating California's largest genomic resource that can be used for translational medicine. A large-scale collection of diverse patient blood, saliva, and tissue samples are genotyped for researchers and clinicians to analyze the data with clinical, environmental, and lifestyle information and deliver the best care to our patients. Patients’ participation is voluntary, and their privacy is protected by de-identifying the samples. Genetic information from this large-scale collection of diverse patient biospecimens is integrated with de-identified clinical information from the patient medical record and made available to UCLA approved researchers.

For more information, please visit the ATLAS Community Health Initiative webpage.

Last updated
November 15, 2023